Search Job Title Only
News By Subject
News by Disease
News By Date
Get Our FREE
) Trims H1 Loss, Meeting
8/21/2009 6:37:54 AM
Reuters -- British drug delivery specialist SkyePharma trimmed first-half losses on lower revenue and said it remain confident about its key new lung drug Flutiform, despite a delay in the United States.
May Need More Flutiform Data
(GEN.CO) Announces 2009 First Half Year Results
(SKYE) Ceases Commercialization of formoterol Certihaler(R) in the United States
Targeted Genetics Corporation
(TGEN) "Must Raise" Cash to Remain in Business Beyond August
(SKYE) Gain on Requip XL Drug Approval
Synovis Life Technologies, Inc.
(SYNO) to Webcast Fiscal Third-Quarter Earnings Conference Call Wednesday, Sept. 2
) Submits Citizen Petition to
Requesting Removal of Bovine Thrombin from Market in the Interest of Patient Safety
Cardinal Health, Inc.
(CAH) Net Profit Falls, But Shares Rise
Issues Warning Letter to
Johnson & Johnson
) Related to Ceftobiprole
Ranking of 20 Drug Companies Shows Sales Force Effectiveness Reaching Plateau
comments powered by Disqus.
comments powered by
Food and Drug Administration (FDA)
Biotech/Pharma - Earnings
Biotech/Pharma - Earnings (World)